PMV Pharmaceuticals Inc

PMVPNASDAQ · USD
1.33USD0.00 (-0.38%)
6610

PMV Pharmaceuticals Inc (PMVP) Covered Calls

As of September 25, 2026, PMVP has 3 covered call opportunities in the coming three months. Return ranges from 86.1 to 268.6% until expiration. Annualized return ranges from 179.3 to 478.3%. The nearest expiration is January 15, 2027. Maximum potential profit is $368.

Read more

Running PMVP covered calls helps you generate consistent income from PMV Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on PMV Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PMVP covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PMVP stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PMVP covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given PMV Pharmaceuticals Inc covered call is worth writing.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013.

PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

Income-focused investors, long-term PMVP holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PMVP covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best PMV Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile59.52% Neutral
  • Market cap (M$)100
  • 52 weeks high-29.26%
  • 52 weeks low30.39%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$4.20
    215.79% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-11
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.41
  • EPS growth next 5 years21.53%

As of September 25, 2026

2027-04-162055.00264.960.052.80368.00268.61478.26-3.65+1.0052.75
2027-01-151142.5082.480.051.40118.0086.13275.77-3.65+0.722,2911.35
2027-04-162052.5082.480.250.80138.00100.73179.35-18.25+0.627780.55

As of September 25, 2026

Sell covered calls with the data behind you

Find the best PMVP covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial